Details for 2019702719
Up to date per 02.04.2026
Actions
Details for 2019702719
Deleted
European Patent
18.11.2020 A
05.03.2025 B1
08.01.2018
US
201862614935 P
07.06.2018
US
201816003006
23.10.2018
US
201862749574 P
G06T 7/11 20170101AFI20240809BHEP
Owner
Progenics Pharmaceuticals, Inc.One World Trade Center 47th Floor, Suite J New York, New York 10007US
Exini Diagnostics ABIdeon Science Park Scheelevägen 27, Gateway 223 70 LundSE
Representative
No representatives present
Inventor
SJÖSTRAND, Karl Vilhelmc/o Progenics Pharmaceuticals, Inc. One World Trade Center, 47th Floor, Suite J New York, New York 10007US
RICHTER, Jens Filip Andreasc/o EXINI Diagnostics AB Ideon Science Park Scheelevägen 27, Gateway 223 70 LundSE
JOHNSSON, Kerstin Elsa Mariac/o EXINI Diagnostics AB Ideon Science Park Scheelevägen 27, Gateway 223 70 LundSE
GJERTSSON, Erik Konradc/o EXINI Diagnostics AB Ideon Science Park Scheelevägen 27, Gateway 223 70 LundSE